SHINE shares update on LEU-based method for Mo-99 production

01/21/2013 | Wisconsin State Journal (Madison)

SHINE Medical Technologies said the Los Alamos National Laboratory had succeeded in producing and separating molybdenum-99 from uranium sulfate solution. SHINE said the development shows the low-enriched uranium-based method can be used to produce the isotope on a commercial scale. The company is looking to meet at least 50% of the U.S. demand for the isotope by 2016.

View Full Article in:

Wisconsin State Journal (Madison)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX